Reperfusion injury in liver transplantation

Current Opinion in Anaesthesiology

Volumn 13, Issue 3, 2000, Pages 349-354

  Tanigawa, Koichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DAMAGE; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; KUPFFER CELL; LIVER TRANSPLANTATION; MEDIATOR RELEASE; MEDICAL RESEARCH; MICROCIRCULATION; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0034080041     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200006000-00020     Document Type: Article

References (67)

1. 1 Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Starzl TE, et al. Effect of cold ischemia on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51:1000-1004.
2. 2 Goode HF, Webster NR, Howdle PD, Leek JP, Lodge J, Sadek SA, et al. Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology 1994; 19:354-359.
3. 3 Bzeizi Kl, Dawkes R, Dodd NJF, Plevris JN, Hayes PC. Graft dysfunction following liver transplantation: role of free radicals. J Hepatol 1997; 26:69-74.
4. 4 Blanc MC, Housset C, Lasnier E, Rey C, Capeau J, Giboudeau J, et al. Direct cytotoxicity of hypoxia-reoxygenation towards sinusoidal endothelial cells in the rat. Liver 1999; 19:42-49. This study demonstrated clear evidence of oxidative injury in cultured sinusoidal endothelial cells by the sequential hypoxia-reoxygenation.
5. 5 Hamer I, Wattiaux R, Wattiaux-De Coninck S. Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia/reperfusion. Biochem Biophys Acta 1995; 1269:145-152.
6. 6 Zar H, Tanigawa K, Kim YM, Lancaster Jr JR. Rat liver postischemic lipid peroxidation and vasoconstriction depend on ischemia time. Free Radic Biol Med 1998; 25:255-264.
7. 7 Zweier JL, Kuppusamy P, Thompson-Gorman S, Klunk D, Lutty GA. Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol 1994; 266:C700-G70B.
8. 8 Angermuller S, Schunk M, Kusterer K. Alteration of xanthine oxidase activity in sinusoidal endothelial cells and morphological changes of Kupffer cells in hypoxic and reoxygenated rat liver. Hepatology 1995; 21:1594-1601.
9. 9 Fujii Y, Johnson ME, Gores GJ. Mitochondrial dysfunction during anoxia/ reoxygenation injury of liver sinusoidal endothelial cells. Hepatology 1994; 20:177-185.
10. 10 Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, et al. Apoptosis of endothelial cells occurs during liver preservation injury by a caspase dependent mechanism. Transplantation 1999; 68:89-96. This is a well-designed study focusing on the role of effector proteases on endothelial cell apoptosis and suggesting the participation of oxygen radicals in its pathogenesis. A caspase inhibitor improved survival remarkably after rat liver transplantation.
11. 11 Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260:G355-G362.
12. 12 Bilzer M, jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 1999; 276:G1137-1144. This study clearly demonstrated Kupffer cell-induced oxidant injury and tried to elucidate the mechanisms by examining the effects of ANP in this event.
13. 13 Ohkohchi N, Shibuya S, Tsukamoto S, Sakurada M, Terashima T, Satomi S. Kupffer's cells modulate neutrophile activity by Superoxide anion and tumor necrosis factor - in reperfusion injury of liver transplantation - mechanisms of radical generation and reperfusion injury after cold ischemia. Transplant Proc 1999; 31:1055-1058. This article focused on the sources of Superoxide in the reperfused liver and discussed the roles of Kupffer cell-induced Superoxide on neutrophil accumulation as well as its interaction with TNF-α.
14. 14 Pesonen EJ, Linder N, Raivio KO, Sarnesto A, Lapatto R, Hockerstedt K, et al. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 1998; 114:1009-1015.
15. 15 Tanigawa K, Kim YM, Lancaster Jr JR, Zar H. Fasting augments lipid peroxidation during reperfusion after ischemia in the perfused rat liver, Crit Care Med 1999; 27:401-406. A marked increase of lipid peroxidation associated with tissue injury was observed on reperfusion in fasted rat livers, suggesting that nutritional support of donors is protective against ROS-induced ischaemia-reperfusion injury.
16. 16 Thies JC, Teklote J, Clauer U, Tox U, Klar E, Hofman WJ, et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transplant Int 1998; 11:S390-S392. Of significance in this clinical pilot study were the effects of N-acetylcysteine on marginal donors. Larger clinical studies are warranted.
17. 17 Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudas L, Halldorson J, et al. Redox gene therapy for ischemia/reperfusion of the liver reduces AP-1 and NF-κB activation. Nat Med 1998; 4:698-704.
18. 18 Kukan M, Vajdova K, Horecky J, Nagyava A, Mehendale HM, Trnovec T. Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology 1997; 26:1250-1257.
19. 19 Schemmer P, Bradford BU, Rose ML, Bunzendahl H, Raleigh JA, Lemasters JJ, et al. Intravenous glycine improves survival in rat liver transplantation. Am J Physiol 1999; 276:G924-G932. Glycine prevents the activation of Kupffer cells and thus ameliorates disturbances in the hepatic microcirculation. Intravenous glycine pretreatment of donors is clinically applicable.
20. 20 Tsukamoto S, Ohkohchi N, Fukumori T, Orii T, Asakura T, Takayama J, et al. Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart-beating donors. Transplantation 1999; 67:1396-1403. No difference was observed in survival between the Kupffer cell eliminated group and the controls. However, transmission electron microphotographs showed well-preserved sinusoid endothelial cells by elimination of Kupffer cells. By adding nafamostat mesilate rinse, a significant improvement of survival was achieved.
21. 21 Bremer C, Bradford BU, Hunt KJ, Knecht KT, Connor HD, Mason RP, et al. Role of Kupffer cells in the pathogenesis of hepatic reperfusion injury. Am J Physiol 1994; 267:G630-G636.
22. 22 Arii S, Imamura M. Liver transplantation and hepatic sinusoidal cells. J Gastroenterol Hepatol 1995; 10:S92-S96.
23. 23 Yamaguchi Y, Matsumura F. Takeya M, Ichiguchi O, Kuratsu J, Horiuchi T, et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 1998; 27:727-734. This is an excellent study elucidating the mechanisms of neutrophil-dependent tissue injury.
24. 24 Cursio R, Gugenheim J, Panaia-Ferrari P, Lasfar A,Tovey M, Chastanet S, et al. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide. J Surg Res 1998; 80:339-344. One of the major findings of this study was the marked improvement of survival in the treatment group. Although normo-or hypothermic ischaemia may have different effects on Kupffer cell activity, these two events coexist in clinical transplantation.
25. 25 Arai M, Peng X, Currin RT, Thurman RG, Lemasters JJ. Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E2 derived from Kupffer cells. Transplantation 1999; 68:440-445. It is very interesting that activated Kupffer cells release protective mediators like prostaglandin E2.
26. 26 Flach R, Speidel N, Flohe S, Borgermann J, Dresen IG, Erhard J, et al. Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 1998; 10:445-461. In most studies cytokine levels were determined in patient plasma, which may not accurately represent cytokine expression in the graft. This study measured intragraft mRNA for cytokines and demonstrated high production of mRNA as a consequence of reperfusion.
27. 27 Mueller AR, Platz K, Haak M, Undi H, Muller C, Kottegen E, et al. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 1996; 62:1118-1126.
28. 28 Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw 18-dependent mechanism, J Immunol 1986; 136:4548-4553.
29. 29 Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 1994; 19:426-431.
30. 30 Bradham CA, Stachlewitz R, Gao W, Qian T, Jayadev S, Jenkins G, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 1997; 25:1128-1135.
31. 31 Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, et al. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 1996; 380:75-79.
32. 32 Wang CY, Mayo MW, Baldwin ASJ. TNF-and cancer therapy-induced apoptosis: potentiation by inhibiting NF-κB. Science 1996; 274:784-787.
33. 33 Selzner M, Camargo CA, Clavien PA. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999; 30:469-475. In a model combining 45 min of ischaemia and 68% hepatectomy, 71% of pretreated rats with recombinant IL-6 survived permanently, whereas all control animals died.
34. 34 Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implication of a central role for nuclear factor κB. Hepatology 1999; 30:203-208. IL-10 has been shown to be protective in ischaemia-reperfusion models and this study provided a new mechanism of its effects.
35. 35 Serizawa A, Nakamura S, Suzuki S, Baba S, Nakano M. Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion. Hepatology 1996; 23:1656-1663.
36. 36 Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intracellular adhesion molecule-1-mediated venular adherence. Surgery 1995; 117:195-200.
37. 37 Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999; 29:1494-1502. A marked reduction of serum transminases and improved survival were achieved in P-selectin-deficient mice.
38. 38 Sawaya DE, Zibari GB, Minardi A, Bilton B, Burney D, Granger DN, et al. P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock 1999; 12:227-232. This study demonstrated changes in leukocyte kinetics in relation to P selectin.
39. 39 Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H. ICAM-1 expression and its role in neutrophil-induced ischemia-reperfusion injury in the rat liver. J Leukocyte Biol 1995; 57:368-374.
40. 40 Marubayashi S, Oshiro Y, Fukuma K, Maeda T, Dohi K. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Transplant Proc 1999; 31:1054.
41. 41 Kushimoto S, Okajima K, Uchiba M, Murakami K, Harada N, Okabe H, et al. Role of granulocyte elastase in ischemia/reperfusion injury in rat liver. Crit Care Med 1996; 24:1908-1912.
42. 42 Soejima Y, Yanaga K, Nishizaki T, Yoshizumi T, Uchiyama H, Sugimachi K. Effects of specific neutrophil elastase inhibitor on inschemia/reperfusion injury in rat liver transplantation. J Surg Res 1999; 86:150-154. ONO-5046, a specific neutrophil elastase inhibitor, ameliorated sinusoid endothelial cell damage.
43. 43 Klein M, Geoghegan J, Wangemann R, Bockler D, Schmidt K, Scheele J. Preconditioning of donor livers with prostaglandin 12 before retrieval decreases hepatocellular ischemia-reperfusion injury. Transplantation 1999; 67:1128-1132. This is a middle-size randomized human study that demonstrated beneficial effects of pretreatment with prostaglandin 12 in the early phase of reperfusion.
44. 44 Neuman UP, Kaisers U, Langrehr JM, Glanemann M, Muller AR, Lang M, et al. Reduction of reperfusion injury with prostacyctin 12 after liver transplantation. Transplant Proc 1999; 31:1029-1030. A relatively small sample size is the major limitation of this study. A larger multicentre clinical study will be needed to determine its effects on graft function and survival.
45. 45 Chen HM, Chen MF, Shyr MH. Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury. J Surg Res 1998; 80:333-338.
46. 46 Giostra E, Chen H, Deng L, Burler L, Romand JA, Hadengue A, et al. Prophylactic administration of prostaglandin E1 in liver transplantation: results of a pilot trial. Transplant Proc 1997; 29:2381-2384.
47. 47 Lou J, Buhler L, Deng S, Mentha G, Montesano R, Grau GE, et al. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 1998; 27:822-828.
48. 48 Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. Surg Today 1999; 29:526-532. This study clearly demonstrated the protective effects of prostaglandin E1 on sinusoid endothelial cells.
49. 49 Henley KS, Lucey MR, Normolle DP. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 1995; 21:366-372.
50. 50 Smith DG, Henley KS, Remmert CS, Mass SL, Campbell Jr DA, McLaren ID. A cost analysis of alprostadil in liver transplantation. Pharmacoeconomics 1996; 9:517-524.
51. 51 Scommotau S, Uhlmann D, Loffler BM, Breu V, Spiegel HU. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg 1999; 384:65-70. An endothelin receptor antagonist and nitric oxide (NO) donor, L-arginine, were used to examine the delicate endothelin-NO balance in a hepatic ischaemia-reperfusion model.
52. 52 Shimamura T, Jin MB, Suzuki T, Iida J, Kishida A, Furukawa H, et al. Nitric oxide enhancement attenuates ischemia and reperfusion injury of canine livers. Transplant Proc 1999; 31:1065-1067. Impressive results were shown in this study. Particularly, L-arginine and a nitric oxide donor (FK409) achieved a significant improvement of survival.
53. 53 Liu P, Yin K, Nagele R, Wong PY. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 1998; 284:1139-1146.
54. 54 Esteban F, Gomez-Jimenez J, Martin MC, Ruiz JC, Nuvials X, Garcia-Allut JL, et al. Nitric oxide and hepatic ischemic injury in human orthotopic liver transplantation. Transplant Proc 1995; 27:2283-2285.
55. 55 Matin-Sanz P, Bosca L, Olmedilla L, Perez-Pena J, Garutti I, Sanz J, et al. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation. Clin Transplant 1999; 13:221-230. This is a carefully designed study including ex-vivo experiments. Identification of the nature of the molecules that mediate this inhibition may provide new clues for understanding of the role of nitric oxide in transplantation.
56. 56 Zhang JX, Bauer M, Clemens MG. Vessel-and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol 1995; 269:G269-G277.
57. 57 Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbance. Hepatology 1994; 19:675-681.
58. 58 Fukunaga K, Takeda Y, Mei G, Taniguchi H, Seino K, Yuzawa K, et al. Endothelin antagonist treatment for successful liver transplantation from non-heart beating donors. Transplantation 1999; 67:328-332. The endothelin antagonist-treated group achieved 83% 7-day survival, whereas no animal survived in the control group. The mechanisms of improved survival remain to be sought.
59. 59 Fukunaga K, Takeda Y, Mei G, Taniguchi H, Seino K, Yuzawa K, et al. An endothelin receptor antagonist ameliorates injuries of sinusoid lining cells in porcine liver transplantation. Am J Surg 1999; 178:64-68. Transmission electron micrograph showed well-preserved endothelial cells at the end of preservation and 1 h after reperfusion, suggesting the association between improved survival and the protection of endothelial cells by the endothelin receptor antagonist.
60. 60 Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldmann G, et al. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transplant Surg 1997; 3:407-415.
61. 61 Kuo PC, Drachenberg Cl, de la Torre A, Bartlett ST, Lim JW, Plotkin JS, et al. Apoptosis and hepatic allograft reperfusion injury. Clin Transplant 1998; 12:219-223.
62. 62 Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27:1652-1660. Strong evidence of endothelial cell apoptosis during reperfusion was demonstrated. Of note is the fact that viable graft had much less apoptosis than non-viable graft.
63. 63 Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67:1099-1105. One of the most important findings in this study was that the susceptibility to apoptosis varies with the type of cells in the liver, and sinusoidal endothelial cells are the most vulnerable.
64. 64 Kohli V, Madden JF, Bentley RC, Clavien PA. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999; 116:168-178. Calpain inhibitor reduced non-parenchymal cell apoptosis significantly, suggesting the possible use of the inhibitor in transplantation.
65. 65 Sindram D, Kohli V, Madden JF, Clavien PA. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. Transplantation 1999; 68:136-140. Both calpain and caspase proteases are involved in endothelial cell apoptosis. However, it was shown that calpain activation would be distal to caspase, suggesting that the inhibition of caspase would also prevent calpain activation, producing a more global cytoprotective effect.
66. 66 Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3:614-620.
67. 67 Bilbao G, Contreras JL, Gomez-Navarro J, Eckhoff DE, Mikheeva G, Krasnykh V, et al. Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation. Transplantation 1999; 67:775-783. The Bcl-2 gene was first discovered in non-Hodgkin's B cell lymphomas. However, no evidence of neoplasia has been demonstrated in transgenic mice with an overexpression of Bcl-2.